Strategic Acquisition Focus Alere has a strong history of acquiring complementary businesses such as Binax and Arriva Medical, which indicates an ongoing strategy to expand its portfolio in diagnostic testing and home healthcare solutions. This suggests opportunities to partner or provide products and services that support their integration and growth initiatives.

Rapid Diagnostic Innovation With multiple product launches like the Alere iCup and Malaria Ag P.f, the company demonstrates a focus on developing innovative, rapid diagnostic solutions for various healthcare needs. There is a potential sales opportunity to introduce cutting-edge technologies in point-of-care testing and infectious disease diagnostics.

Expanding Market Reach Operating in over 160 countries with a large workforce, Alere is positioned for global market expansion. This broad geographic presence opens avenues for sales expansion through local distributors, regional partnerships, and tailored healthcare solutions targeting emerging markets.

Healthcare Industry Integration As part of Abbott since 2017, Alere benefits from Abbott's extensive distribution channels and healthcare network. Leveraging this integrated infrastructure can facilitate multi-product sales and cross-promotional opportunities within Abbott’s extensive portfolio.

Growth in Healthcare Sectors Alere's focus on diagnostics, medical devices, and nutritionals aligns with growing trends in personalized medicine, self-care, and home diagnostics. Selling complementary products or services that enhance these areas can tap into increased demand driven by healthcare consumerization and pandemic-related health monitoring.